Business Daily Are weight-loss drugs reshaping business?
Mar 4, 2026
Sandra Boboso, a health economist who studies obesity costs and drug impacts, and Gabe Zickerman, founder of protein, no-added-sugar ice cream Two Scoops. They discuss how GLP-1 drugs widened consumer demand, how food and fitness businesses are adapting, shifting shopping habits and spending, and the likely future of prices, access and market opportunities.
AI Snips
Chapters
Transcript
Episode notes
Niche Ice Cream Built Around GLP-1 Users
- Gabe Zickerman built Two Scoops to serve people on GLP-1s with high-protein, no-added-sugar desserts.
- He redesigned components (zero-sugar high-protein marshmallow, allulose sweetener) to make Rocky Road with 30g protein per pint taste like indulgence.
GLP-1s Will Reshape Food Demand And Pricing
- GLP-1 drugs are reshaping food demand toward higher protein, lower sugar, and new portion sizes.
- Gabe predicts higher price-per-gram because protein costs more and users need protein-fortified foods to maintain muscle on GLP-1s.
Make GLP-1 Support Core To Food Business Plans
- Businesses entering the food market should make GLP-1 support core to their plan.
- Gabe advises that companies ignoring GLP-1 users risk missing a major, enduring customer segment.